Key facts
- Sonara’s last known valuation is $13.0M (Oct 2022).
- It has raised $10.2M; the latest was Later Stage VC ($4.4M) in Aug 2025.
- Notable investors include VentureWell, Mark Cuban, First Trust Capital Partners, Sorenson Impact Foundation, Oakwood Circle Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Sonara
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonara are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonara
Developer of a telehealth software designed to meet the specific needs of opioid addiction clinics and their patients. The company's software guides patients through their journey to recovery while providing their care team with the information needed to improve treatment plans, initiate timely interventions and expand access to care, enabling patients to overcome opioid addiction, thereby saving lives.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2020
- Employees
- 20
- Website
- sonarahealth.com/
- Ownership
- Privately Held (backing)
Sonara doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonara shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonara in its N-PORT filings yet. We sweep new filings monthly.